- Home
- LSTA vs OPI Comparison
LSTA vs OPI Comparison
Compare LSTA & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- OPI
- Stock Information
- Founded
- LSTA 1980
- OPI 2009
- Country
- LSTA United States
- OPI United States
- Employees
- LSTA N/A
- OPI 1000
- Industry
- LSTA Misc Health and Biotechnology Services
- OPI Real Estate Investment Trusts
- Sector
- LSTA Health Care
- OPI Real Estate
- Exchange
- LSTA Nasdaq
- OPI Nasdaq
- Market Cap
- LSTA 20.9M
- OPI 17.7M
- IPO Year
- LSTA N/A
- OPI 2009
- Fundamental
- Price
- LSTA $2.94
- OPI $0.23
- Analyst Decision
- LSTA Strong Buy
- OPI
- Analyst Count
- LSTA 1
- OPI 0
- Target Price
- LSTA $15.00
- OPI N/A
- AVG Volume (30 Days)
- LSTA 9.3K
- OPI 1.5M
- Earning Date
- LSTA 08-11-2025
- OPI 07-30-2025
- Dividend Yield
- LSTA N/A
- OPI 17.48%
- EPS Growth
- LSTA N/A
- OPI N/A
- EPS
- LSTA N/A
- OPI N/A
- Revenue
- LSTA $1,000,000.00
- OPI $476,159,000.00
- Revenue This Year
- LSTA N/A
- OPI N/A
- Revenue Next Year
- LSTA N/A
- OPI N/A
- P/E Ratio
- LSTA N/A
- OPI N/A
- Revenue Growth
- LSTA N/A
- OPI N/A
- 52 Week Low
- LSTA $1.87
- OPI $0.18
- 52 Week High
- LSTA $4.20
- OPI $3.02
- Technical
- Relative Strength Index (RSI)
- LSTA 66.20
- OPI 46.70
- Support Level
- LSTA $2.36
- OPI $0.18
- Resistance Level
- LSTA $2.69
- OPI $0.30
- Average True Range (ATR)
- LSTA 0.20
- OPI 0.02
- MACD
- LSTA 0.01
- OPI 0.01
- Stochastic Oscillator
- LSTA 90.77
- OPI 35.27
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.